Disease Markers / 2019 / Article / Tab 2

Research Article

Maternal Serum Angiogenic Factor sFlt-1 to PlGF Ratio in Preeclampsia: A Useful Marker for Differential Diagnosis and Prognosis Evaluation in Chinese Women

Table 2

sFlt-1/PlGF ratio in PE, GH, chrHTN, and healthy controls.

GroupPE ()Control ()GH ()chrHTN ()
<34 wks≥34 wks<34 wks≥34 wks<34 wks≥34 wks<34 wks≥34 wks

Total ()4814591757105
sFlt-1/PlGF ratio

aThe comparison of the sFlt-1/PlGF ratio between <34 weeks and ≥34weeks subgroups showed that PE patients <34 weeks had a significant higher average sFlt-1/PlGF ratio than patients ≥34 weeks; controls <34 weeks significantly decreased than controls ≥34 weeks.